Fischer Medical Ventures Ltd
Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]
- Market Cap ₹ 3,386 Cr.
- Current Price ₹ 633
- High / Low ₹ 793 / 94.3
- Stock P/E 1,840
- Book Value ₹ 15.1
- Dividend Yield 0.00 %
- ROCE 5.30 %
- ROE 4.60 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 42.0 times its book value
- Company has high debtors of 398 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | |
|---|---|---|
| 0.18 | 20.98 | |
| 0.16 | 19.12 | |
| Operating Profit | 0.02 | 1.86 |
| OPM % | 11.11% | 8.87% |
| 0.00 | 0.50 | |
| Interest | 0.02 | 0.07 |
| Depreciation | 0.00 | 0.18 |
| Profit before tax | 0.00 | 2.11 |
| Tax % | 12.80% | |
| -0.04 | 1.84 | |
| EPS in Rs | -2.33 | 0.34 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 11556% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 4700% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 71% |
| 5 Years: | 59% |
| 3 Years: | 96% |
| 1 Year: | 571% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|
| Equity Capital | 0.17 | 53.50 | 53.50 |
| Reserves | -0.44 | 26.74 | 27.08 |
| 0.57 | 1.68 | 1.47 | |
| 0.05 | 4.40 | 58.67 | |
| Total Liabilities | 0.35 | 86.32 | 140.72 |
| 0.00 | 14.71 | 14.87 | |
| CWIP | 0.00 | 0.00 | 2.89 |
| Investments | 0.00 | 1.21 | 11.70 |
| 0.35 | 70.40 | 111.26 | |
| Total Assets | 0.35 | 86.32 | 140.72 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | |
|---|---|---|
| -7.59 | ||
| -28.61 | ||
| 37.11 | ||
| Net Cash Flow | 0.91 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | |
|---|---|---|
| Debtor Days | 344.72 | 397.88 |
| Inventory Days | ||
| Days Payable | ||
| Cash Conversion Cycle | 344.72 | 397.88 |
| Working Capital Days | 324.44 | 505.40 |
| ROCE % | 5.30% |
Documents
Announcements
-
Update Of Incorporation Of Subsidiary Company
14 Nov - Incorporation of Wondertech Medical Solutions Private Limited.
-
RESULTS 30/09/2024
14 Nov - Approved financial results and CFO appointment.
-
Board Meeting Outcome for OUTCOME OF BOARD MEETING
14 Nov - Approval of financial results and CFO appointment.
-
Update on board meeting
5 Nov - Board meeting scheduled for Q2 financial results.
-
Board Meeting Scheduled On 13/11/2024 To Consider And Approve Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2024
5 Nov - Board meeting scheduled for Q2 financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals